RE:THRMOnce Acuvid is FDA EUA approved, I would think airports and cruises would be the major contracts in terms of domestic sales. For international, the demand is going to sky rocket (India, South America, Africa, middle east and Europe. I personally think it will be $8/share on FDA approval, then $19 per share on domestic contracts and $85/share on international contracts. With Venowave and Benepod sales in addition on top of white labeling, I see this going to $130/share by mid June 2022.